Bruce Carpick

1.2k total citations
26 papers, 1.0k citations indexed

About

Bruce Carpick is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Bruce Carpick has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Immunology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Bruce Carpick's work include Protein purification and stability (7 papers), RNA and protein synthesis mechanisms (7 papers) and RNA regulation and disease (6 papers). Bruce Carpick is often cited by papers focused on Protein purification and stability (7 papers), RNA and protein synthesis mechanisms (7 papers) and RNA regulation and disease (6 papers). Bruce Carpick collaborates with scholars based in Canada, United States and France. Bruce Carpick's co-authors include Bryan Williams, Jun Qin, S. Nanduri, Yanwu Yang, Jean Gariépy, Wen-Ming Chu, Carl W. Schmid, Marina Kirkitadze, Dieter K. Schneider and Xavier Lee and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Molecular and Cellular Biology.

In The Last Decade

Bruce Carpick

26 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce Carpick Canada 13 782 223 109 87 79 26 1.0k
Alex G. Johnson United States 14 830 1.1× 196 0.9× 103 0.9× 50 0.6× 152 1.9× 17 1.2k
Fumiko Nishikawa Japan 23 1.0k 1.3× 350 1.6× 147 1.3× 49 0.6× 124 1.6× 70 1.5k
Gerbrand J. van der Heden van Noort Netherlands 20 689 0.9× 170 0.8× 123 1.1× 32 0.4× 121 1.5× 57 1.0k
Benoı̂t de Chassey France 16 535 0.7× 208 0.9× 233 2.1× 40 0.5× 125 1.6× 25 910
Elisabetta Pizzi Italy 19 789 1.0× 245 1.1× 152 1.4× 39 0.4× 100 1.3× 44 1.3k
Emily Locke United States 19 605 0.8× 232 1.0× 129 1.2× 143 1.6× 118 1.5× 42 1.3k
Natalia Beloglazova Canada 17 937 1.2× 103 0.5× 190 1.7× 47 0.5× 80 1.0× 23 1.1k
Patricia M. Legler United States 17 670 0.9× 214 1.0× 88 0.8× 56 0.6× 114 1.4× 47 1.1k
Marc H. V. Van Regenmortel France 11 481 0.6× 158 0.7× 54 0.5× 91 1.0× 91 1.2× 15 884

Countries citing papers authored by Bruce Carpick

Since Specialization
Citations

This map shows the geographic impact of Bruce Carpick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Carpick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Carpick more than expected).

Fields of papers citing papers by Bruce Carpick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Carpick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Carpick. The network helps show where Bruce Carpick may publish in the future.

Co-authorship network of co-authors of Bruce Carpick

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Carpick. A scholar is included among the top collaborators of Bruce Carpick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Carpick. Bruce Carpick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cronin, James T., et al.. (2019). Aluminum Phosphate Vaccine Adjuvant: Analysis of Composition and Size Using Off-Line and In-Line Tools. Computational and Structural Biotechnology Journal. 17. 1184–1194. 18 indexed citations
3.
4.
James, D. Andrew, et al.. (2018). Detection of Residual Proteins UL5 and UL29 Using a Targeted Proteomics Approach in HSV529, a Replication-Deficient HSV-2 Vaccine Candidate. Journal of Pharmaceutical Sciences. 107(12). 3022–3031. 4 indexed citations
5.
Khatun, Rahima, Howard N. Hunter, Yi Sheng, Bruce Carpick, & Marina Kirkitadze. (2018). 27Al and 31P NMR spectroscopy method development to quantify aluminum phosphate in adjuvanted vaccine formulations. Journal of Pharmaceutical and Biomedical Analysis. 159. 166–172. 10 indexed citations
6.
Morin, Sylvie, et al.. (2018). Identity, Structure and Compositional Analysis of Aluminum Phosphate Adsorbed Pediatric Quadrivalent and Pentavalent Vaccines. Computational and Structural Biotechnology Journal. 17. 14–20. 12 indexed citations
7.
Carpick, Bruce, et al.. (2018). Tuberculosis vaccine candidate: Characterization of H4-IC31 formulation and H4 antigen conformation. Journal of Pharmaceutical and Biomedical Analysis. 157. 235–243. 10 indexed citations
8.
Hu, Jian, et al.. (2017). Differential Scanning Calorimetry — A Method for Assessing the Thermal Stability and Conformation of Protein Antigen. Journal of Visualized Experiments. 87 indexed citations
9.
10.
Khatun, Rahima, et al.. (2016). Nuclear Magnetic Resonance (NMR) Study for the Detection and Quantitation of Cholesterol in HSV529 Therapeutic Vaccine Candidate. Computational and Structural Biotechnology Journal. 15. 14–20. 17 indexed citations
11.
Kirkitadze, Marina, et al.. (2016). Visible and subvisible particles in the BCG immunotherapeutic product ImmuCyst®. Computational and Structural Biotechnology Journal. 14. 154–160. 3 indexed citations
12.
Kirkitadze, Marina, Balasubramanian Arunachalam, & Bruce Carpick. (2013). Comparability of biotherapeutics: characterization of protein vaccine antigens. Zenodo (CERN European Organization for Nuclear Research). 1(4). 373–380. 6 indexed citations
13.
Oloo, E.O., Jeremy A. Yethon, Martina M. Ochs, Bruce Carpick, & Raymond P. Oomen. (2011). Structure-guided Antigen Engineering Yields Pneumolysin Mutants Suitable for Vaccination against Pneumococcal Disease. Journal of Biological Chemistry. 286(14). 12133–12140. 27 indexed citations
14.
Carpick, Bruce, et al.. (2000). HIV-I TAT Inhibits PKR Activity by Both RNA-Dependent and RNA-Independent Mechanisms. Archives of Biochemistry and Biophysics. 373(2). 361–367. 73 indexed citations
15.
Chu, Wen-Ming, et al.. (1998). Potential Alu Function: Regulation of the Activity of Double-Stranded RNA-Activated Kinase PKR. Molecular and Cellular Biology. 18(1). 58–68. 167 indexed citations
16.
Nanduri, S., Bruce Carpick, Yanwu Yang, Bryan Williams, & Jun Qin. (1998). 1H, 13C, 15N Resonance Assignment of the 20 kDa Double Stranded RNA Binding Domain of PKR. Journal of Biomolecular NMR. 12(2). 349–351. 18 indexed citations
17.
Nanduri, S., Bruce Carpick, Yanwu Yang, Bryan Williams, & Jun Qin. (1998). Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation. The EMBO Journal. 17(18). 5458–5465. 264 indexed citations
18.
Carpick, Bruce, Vito Graziano, Dieter K. Schneider, et al.. (1997). Characterization of the Solution Complex between the Interferon-induced, Double-stranded RNA-activated Protein Kinase and HIV-I Trans-activating Region RNA. Journal of Biological Chemistry. 272(14). 9510–9516. 113 indexed citations
19.
McMillan, Nigel A.J., et al.. (1995). Mutational Analysis of the Double-stranded RNA (dsRNA) Binding Domain of the dsRNA-activated Protein Kinase, PKR. Journal of Biological Chemistry. 270(6). 2601–2606. 78 indexed citations
20.
Carpick, Bruce & Jean Gariépy. (1991). Structural characterization of functionally important regions of the Escherichia coli heat-stable enterotoxin STIb. Biochemistry. 30(19). 4803–4809. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alex G. Johnson Breakdown of academic impact, for papers by Fumiko Nishikawa Breakdown of academic impact, for papers by Gerbrand J. van der Heden van Noort Breakdown of academic impact, for papers by Benoı̂t de Chassey Breakdown of academic impact, for papers by Elisabetta Pizzi Breakdown of academic impact, for papers by Emily Locke Breakdown of academic impact, for papers by Natalia Beloglazova Breakdown of academic impact, for papers by Patricia M. Legler Breakdown of academic impact, for papers by Marc H. V. Van Regenmortel
Rankless by CCL
2026